A Year of Transformation: Shaping the Future of Health Through Therapeutic Plasma Exchange

The beginning of 2025 is the perfect time to reflect on an incredible year of transformation at MDLifespan. In 2024, we made remarkable progress in our mission to combat the growing crisis of environmental toxins and empower individuals to reclaim their health. At the heart of this progress lies our Therapeutic Plasma Exchange (TPE) Protocol, a revolutionary approach to toxin reduction and health enhancement. 

Through the dedication of our team, the trust of our patients, and the collaboration of our partners, we have achieved outcomes that are reshaping modern health optimization.

Over the past year, our PlasmaXchange Protocol delivered groundbreaking results: 

PlasmaXchange: Improved Aging Biomarkers 

• 📉 Oxidation levels reduced by 75% 

• 📉 Senescence (precancer cells) reduced by 66% 

• 📉 Inflammation dropped by 40–60% 

• 📈 NAD levels increased by 50% 

• 📈 Immune system strength improved by 15% 
• 📉 Glycated proteins (sugar) reduced by 15% 

PlasmaXchange: Environmental Toxin Reductions 

• ✅ Parabens reduced by 66–85% (Ethylparaben & Methylparaben) 

• ✅ Pesticides reduced by 66% (e.g., Dimethyldithiophosphate – DMDTP) 

• ✅ Herbicides reduced by 25–66% (e.g., 2,4-D, Atrazine, Glyphosate/Round-Up) 

• ✅ Phenol (BPA) reduced by 35% 

PlasmaXchange: Heavy Metal Detoxification 

• ✅ 90–100% reduction: Aluminum, Gadolinium, Tin, Tungsten 

• ✅ 50–89% reduction: Lead, Nickel, Thorium 

• ✅ 25–49% reduction: Arsenic, Mercury, Tellurium, Uranium 

These results underscore the transformative potential of TPE in addressing the root causes of chronic illness, reducing inflammation, and supporting long-term health. 

In 2024, MDLifespan expanded its reach like never before. With over 300 TPE procedures performed, we were able to improve the health and well-being of individuals across the country. Our growing network of providers has made it possible to bring PlasmaXchange to more communities, empowering more people to lead toxin-free, vibrant lives. 

As we step into 2025, our commitment to tackling environmental toxins, reducing illness, and enhancing quality of life is stronger than ever. We remain dedicated to driving innovation and impact through personalized care, cutting-edge therapies, and a relentless focus on improving optimized wellness. 

“The future of health lies in addressing the root causes of chronic disease—environmental toxins and inflammation. Through PlasmaXchange, we are empowering individuals to reclaim their health and thrive,” says Dr. Paul Savage, founder of MDLifespan. 

To all our patients, partners, and advocates—thank you for believing in our mission. Together, we are paving the way for a healthier and more vibrant future. 

Here’s to a year of continued innovation, impact, and well-being in 2025!